Home  »  Company   »  Creative Medical Technology Holdings Inc. (NASDAQ:...

Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) Currently -1452.5% Below Its 52-Week High But The Downside Potential May Surprise You

In last trading session, Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) saw 0.21 million shares changing hands with its beta currently measuring 4.67. Company’s recent per share price level of $0.40 trading at $0.01 or 2.83% at ring of the bell on the day assigns it a market valuation of $5.60M. That closing price of CELZ’s stock is at a discount of -1452.5% from its 52-week high price of $6.21 and is indicating a premium of 17.5% from its 52-week low price of $0.33. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 447.56K if we extend that period to 3-months.

Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) trade information

Upright in the green during last session for gaining 2.83%, in the last five days CELZ remained trading in the green while hitting it’s week-highest on Friday, 11/18/22 when the stock touched $0.40 price level, adding 3.59% to its value on the day. Creative Medical Technology Holdings Inc.’s shares saw a change of -81.90% in year-to-date performance and have moved 2.54% in past 5-day. Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) showed a performance of -6.78% in past 30-days. Number of shares sold short was 46100.0 shares which calculate 0.22 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Creative Medical Technology Holdings Inc. (CELZ) estimates and forecasts

This year revenue growth is estimated to rise 388.60% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $110k for the same. And 1 analysts are in estimates of company making revenue of $310k in the next quarter that will end on Dec 2022.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 15.00% during past 5 years.

CELZ Dividends

Creative Medical Technology Holdings Inc. is more likely to be releasing its next quarterly report in December and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Creative Medical Technology Holdings Inc. (NASDAQ:CELZ)’s Major holders

Insiders are in possession of 2.36% of company’s total shares while institution are holding 15.56 percent of that, with stock having share float percentage of 15.94%. Investors also watch the number of corporate investors in a company very closely, which is 15.56% institutions for Creative Medical Technology Holdings Inc. that are currently holding shares of the company. Armistice Capital, LLC is the top institutional holder at CELZ for having 1.24 million shares of worth $0.93 million. And as of Jun 29, 2022, it was holding 50.73% of the company’s outstanding shares.

The second largest institutional holder is Boothbay Fund Management, LLC, which was holding about 88889.0 shares on Jun 29, 2022. The number of shares represents firm’s hold over 3.62% of outstanding shares, having a total worth of $66666.0.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 61050.0 shares of worth $45787.0 or 2.49% of the total outstanding shares. The later fund manager was in possession of 24240.0 shares on Jun 29, 2022, making its stake of worth around $18180.0 in the company or a holder of 0.99% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]